| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/21/2002 | WO2001030375A3 Use of gdnf for treating corneal defects |
| 03/21/2002 | WO2000078772A3 Antibiotic agents |
| 03/21/2002 | US20020035357 Osmotic device within an osmotic device |
| 03/21/2002 | US20020035346 Drug release (delivery system) |
| 03/21/2002 | US20020035264 Therapy for vision disorders |
| 03/21/2002 | US20020035248 Granules based on starch and lactose |
| 03/21/2002 | US20020035217 Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules |
| 03/21/2002 | US20020035182 Oil in water emulsion |
| 03/21/2002 | US20020035168 Bioresorbable hydrogel compositions for implantable prostheses |
| 03/21/2002 | US20020035161 O/W emulsions comprising micronized biologically active agents |
| 03/21/2002 | US20020035160 Topical applying; stability |
| 03/21/2002 | US20020035154 Use of certain fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions |
| 03/21/2002 | US20020035152 Use of inhaled retinoids in the treatment of lung diseases |
| 03/21/2002 | US20020035151 Calcium formate for use as a dietary supplement |
| 03/21/2002 | US20020035150 Adminstering a cannabinoid compound |
| 03/21/2002 | US20020035142 Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids |
| 03/21/2002 | US20020035135 Oral administering; storage stability |
| 03/21/2002 | US20020035131 Administering paroxetine |
| 03/21/2002 | US20020035130 Antidepressants, therapy for Parkinson's disease |
| 03/21/2002 | US20020035119 Bioavailable dosage form of loratadine |
| 03/21/2002 | US20020035107 Highly concentrated stable meloxicam solutions |
| 03/21/2002 | US20020035096 Formulations for treating or preventing mucositis |
| 03/21/2002 | US20020035093 Methods for the administration of amifostine and related compounds |
| 03/21/2002 | US20020035088 Formulated at a certain pH in order to minimize or eliminate compatibility problems between tobramycin and xanthan gum; eye, nose, ear topical solutions |
| 03/21/2002 | US20020035084 Protecting the agent (such as chemotherapeutic agent) within a lipid structure, causing lipase activity to be constituted in response to predetermined conditions, and exposing the lipid structure to release the agent |
| 03/21/2002 | US20020035082 Lipids where the glycerol backbone is replaced with a carbohydrate; conjugates; drug delivery |
| 03/21/2002 | US20020035076 Method of treating dermatoses using avermectin compound |
| 03/21/2002 | US20020034822 Integrative protein-DNA cochleate formulations and methods for transforming cells |
| 03/21/2002 | US20020034592 Electrostatic coating |
| 03/21/2002 | US20020034554 Enhancing permeation of skin or mucosal tissue with topical hydroxide- releasing agent and lipophilic co-enhancer |
| 03/21/2002 | US20020034552 Micro- and nano- particles from oppositely charged, enzyme degradable polymers in which a drug is incorporated into the core and is conjugated by a Schiff-base crossling |
| 03/21/2002 | US20020034551 Method of making microencapsulated DNA for vaccination and gene therapy |
| 03/21/2002 | US20020034549 And plasticizer; for pharmaceutical dosage forms, food and confectionery tablets, seeds and granule cores |
| 03/21/2002 | US20020034548 Ascorbic acid, cationic polymers, cationic surfactants, humectants, polymers with humectant properties, inorganic driers; antiinflammatory agents, skin damage prevention, cosmetics |
| 03/21/2002 | US20020034546 Pharmaceutical composition containing a combination of a statin and aspirin and method |
| 03/21/2002 | US20020034545 Particulate composition of eletriptan |
| 03/21/2002 | US20020034544 Controlled release pharmaceutical composition for oral use containing midodrine and/or active metabolite, desglymidodrine |
| 03/21/2002 | US20020034543 Nutritional composition |
| 03/21/2002 | US20020034542 Pharmaceutically acceptable steam extruded polymer, and medicament; rapid oral drug delivery or as vaginal or rectal suppositories or for oral delivery of veterinary drugs |
| 03/21/2002 | US20020034541 Oral solid pharmaceutical formulations with pH-dependent multiphasic release |
| 03/21/2002 | US20020034540 Solid non-effervescent compressed dosage form comprising an ibuprofen medicament and an alkali metal carbonate or bicarbonate carrier material and compressible filler component combined with disintegrating component |
| 03/21/2002 | US20020034539 Biphasic multicomponent pharamaceutical dosage forms containing substances able to modify the partitioning of drugs |
| 03/21/2002 | US20020034538 Liposomal benzoquinazolne thymidylate synthase inhibitor formulations |
| 03/21/2002 | US20020034537 For enhancing selective delivery of therapeutic, diagnostic and imaging agents to activated vascular sites |
| 03/21/2002 | US20020034536 Novel particulate formulations |
| 03/21/2002 | US20020034535 Rate controlling membranes for controlled drug delivery devices |
| 03/21/2002 | US20020034534 Receptor loading dosage form containing therapeutic agent and extended-release dosage form containing therapeutic agent administered concurrently |
| 03/21/2002 | US20020034533 Bioerodable polymeric adhesives for tissue repair |
| 03/21/2002 | US20020034532 Injectable depot gel composition and method of preparing the composition |
| 03/21/2002 | US20020034530 In ovo delivery of an immunogen containing implant |
| 03/21/2002 | US20020034528 Cosmetic, dermatological, hygiene and/or pharmaceutical composition |
| 03/21/2002 | US20020034526 Cosmetic, dermatological, hygiene and/or pharmaceutical composition |
| 03/21/2002 | US20020034514 Administering microsphere of immunogens; enteric overcoatings |
| 03/21/2002 | US20020034505 Genetic enginnering; kits |
| 03/21/2002 | US20020034499 Nutrient medium which can be used as a culture medium for epidermal cells and applications |
| 03/21/2002 | US20020034477 Dry powder; complex |
| 03/21/2002 | US20020034474 Drug targeting system, method of its preparation and its use |
| 03/21/2002 | US20020034455 Mixture containing surfactant and foam stabilizer |
| 03/21/2002 | US20020033174 Inhalable aerosol medicament for the treatment or prevention of pain |
| 03/21/2002 | DE10045047A1 Arzneimittel enthaltend aktiviertes Antithrombin III Medicines containing activated antithrombin III |
| 03/21/2002 | DE10044299A1 Multipartikuläre Arzneiform und Verfahren zu ihrer Herstellung Multiparticulate dosage form and processes for their preparation |
| 03/21/2002 | DE10026678C1 Transdermal patch for delivery of non-steroidal antiinflammatory agent, containing e.g. alkyl-pyrrolidone, metal salt, surfactant and polymers, provides good drug release and absorption properties |
| 03/21/2002 | CA2422829A1 Patch comprising diclofenac |
| 03/21/2002 | CA2422828A1 Novel tumor-associated marker |
| 03/21/2002 | CA2422586A1 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | CA2422575A1 Composition comprising immunogenic microparticles |
| 03/21/2002 | CA2421966A1 Remedies for ischemic diseases |
| 03/21/2002 | CA2421585A1 Method and composition for treating tumors by selective induction of apoptosis |
| 03/21/2002 | CA2416563A1 Pharmaceutical composition having specific water activity |
| 03/21/2002 | CA2406446A1 Diphosphonate solutions |
| 03/21/2002 | CA2391162A1 Novel topical oestroprogestational compositions with systemic effect |
| 03/20/2002 | EP1188445A1 Drug composition containing lecithin-modified superoxide dismutase |
| 03/20/2002 | EP1188441A1 Oral preparations of etidronate disodium |
| 03/20/2002 | EP1188440A1 Medicinal composition for oral administration |
| 03/20/2002 | EP1188436A2 Percutaneously absorptive preparation |
| 03/20/2002 | EP1188435A1 Intraoral adhesive preparation |
| 03/20/2002 | EP1188434A1 Ophthalmic pharmaceutical composition |
| 03/20/2002 | EP1188383A1 Method for production of arachidonic acid |
| 03/20/2002 | EP1188057A2 Incorporation and appliations of biomolecular interactions within a carrier |
| 03/20/2002 | EP1187929A2 Novel liposomal vector complexes and their use in gene therapy |
| 03/20/2002 | EP1187907A1 Method for the preservation of biologically-active material |
| 03/20/2002 | EP1187838A1 Thiazolopyrimidines useful as tnf-alpha inhibitors |
| 03/20/2002 | EP1187807A1 Bipolar lipids and their use for the delivery of bioactive substances |
| 03/20/2002 | EP1187803A1 Amorphous nitric esters and their pharmaceutical compositions |
| 03/20/2002 | EP1187639A1 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same |
| 03/20/2002 | EP1187636A1 Injectable hyaluronate-sulfated polysaccharide conjugates |
| 03/20/2002 | EP1187635A1 Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist |
| 03/20/2002 | EP1187622A1 Method of sterilizing |
| 03/20/2002 | EP1187618A1 Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use |
| 03/20/2002 | EP1187611A2 Ophthalmic histamine compositions and uses thereof |
| 03/20/2002 | EP1187602A1 Injectable sustained release pharmaceutical composition and processes for preparing the same |
| 03/20/2002 | EP1187601A1 Novel preparation and administration form comprising an acid-labile active compound |
| 03/20/2002 | EP1187600A1 Method for enhancing stable cellular creatine concentration |
| 03/20/2002 | EP1187599A1 Stable benzimidazole formulation |
| 03/20/2002 | EP1187539A1 Method and composition for masking mineral taste |
| 03/20/2002 | EP1143796A4 Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method |
| 03/20/2002 | EP1109540A4 Extended release acetaminophen |
| 03/20/2002 | EP1077687B1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 03/20/2002 | EP1033975B1 Method for producing solvent-free non-crystalline biologically active substances |
| 03/20/2002 | EP1017696B1 Acidic addition salts of morphine alkaloids and the application thereof |